{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:09:01Z","timestamp":1793398141304,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","award":["69395709"],"award-info":[{"award-number":["69395709"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.113992","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:55:57Z","timestamp":1751025357000},"page":"113992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Innovative solid lipid nanoparticle formulations for ocular therapeutics and related patents: A systematic review"],"prefix":"10.1016","volume":"385","author":[{"given":"Bakr","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veluchamy A.","family":"Barathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana B.","family":"Patravale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu Pal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113992_bb0005","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2025.113992_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070321","article-title":"Penetration enhancers in ocular drug delivery","volume":"11","author":"Moiseev","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.113992_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/polym10121379","article-title":"Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications","volume":"10","author":"Stewart","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2025.113992_bb0030","first-page":"1","article-title":"Lipid-based drug delivery systems","volume":"2014","author":"Shrestha","year":"2014","journal-title":"J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113992_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071952","article-title":"A new era in ocular therapeutics: advanced drug delivery systems for uveitis and neuro-ophthalmologic conditions","volume":"15","author":"Wu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.113992_bb0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/acsomega.2c05976","article-title":"Surface modification of lipid-based nanocarriers: a potential approach to enhance targeted drug delivery","volume":"8","author":"Priya","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2025.113992_bb0050","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.2147\/IJN.S340068","article-title":"Assessment to the antifungal effects in vitro and the ocular pharmacokinetics of solid-lipid nanoparticle in rabbits","volume":"16","author":"Liang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113992_bb0055","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.3390\/molecules26154673","article-title":"Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: in vivo evidence","volume":"26","author":"Puglia","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.113992_bb0060","article-title":"Development and optimization of solid lipid nanoparticles coated with chitosan and poly(2-ethyl-2-oxazoline) for ocular drug delivery of ciprofloxacin","volume":"74","author":"Onugwu","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106494","article-title":"The effect of charges on the corneal penetration of solid lipid nanoparticles loaded Econazole after topical administration in rabbits","volume":"187","author":"Liang","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.113992_bb0070","author":"Hesham"},{"key":"10.1016\/j.jconrel.2025.113992_bb0075","author":"Soumyajit Majumdar"},{"key":"10.1016\/j.jconrel.2025.113992_bb0080","author":"Beck"},{"key":"10.1016\/j.jconrel.2025.113992_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204781","article-title":"Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method","volume":"25","author":"Duong","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.113992_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.colsurfb.2019.05.061","article-title":"Enhanced storage stability of solid lipid nanoparticles by surface modification of comb-shaped amphiphilic inulin derivatives","volume":"181","author":"Peng","year":"2019","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.jconrel.2025.113992_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jconrel.2025.113992_bb0100","article-title":"Development and optimization of ofloxacin as solid lipid nanoparticles for enhancement of its ocular activity","volume":"72","author":"Alhakamy","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0105","article-title":"Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: a promising approach towards treating diabetic retinopathy","volume":"X 7","author":"Ramadan","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113992_bb0110","article-title":"Formulation, optimization and evaluation of vitamin E TPGS emulsified dorzolamide solid lipid nanoparticles","volume":"68","author":"Shahab","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0115","article-title":"In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: in vitro and ex vivo evaluation","volume":"56","author":"Wadetwar","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0120","article-title":"Loteprednol loaded nanoformulations for corneal delivery: ex-vivo permeation study, ocular safety assessment and stability studies","volume":"81","author":"Uner","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0125","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.msec.2019.03.060","article-title":"Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: characterization, pharmacokinetic and deposition study","volume":"100","author":"Ahmad","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2025.113992_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122682","article-title":"Pre-clinical safety of topically administered sunitinib-loaded lipid and polymeric nanocarriers targeting corneal neovascularization","volume":"635","author":"Gomes Souza","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113992_bb0135","article-title":"Preparation, optimization, and transcorneal permeability study of lutein-loaded solid lipid nanoparticles","volume":"62","author":"Tan","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0140","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/pharmaceutics15071855","article-title":"Chitosan-coated SLN: a potential system for ocular delivery of metronidazole","volume":"15","author":"Sikhondze","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0145","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/pharmaceutics13111956","article-title":"Sorafenib repurposing for ophthalmic delivery by lipid nanoparticles: a preliminary study","volume":"13","author":"Bonaccorso","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/pharmaceutics13040523","article-title":"Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation, and in vivo studies","volume":"13","author":"Nair","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0155","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s13346-020-00777-6","article-title":"Correction to: atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD)","volume":"10","author":"Yadav","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.113992_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/nano9010033","article-title":"In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: tear kinetics and ocular disposition studies","volume":"9","author":"Tatke","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2025.113992_bb0165","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.2147\/IJN.S335482","article-title":"Formulation and pathohistological study of mizolastine-solid lipid nanoparticles-loaded ocular hydrogels","volume":"16","author":"El-Emam","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113992_bb0170","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/ph16071001","article-title":"Ocular delivery of bimatoprost-loaded solid lipid nanoparticles for effective management of glaucoma","volume":"16","author":"Satyanarayana","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2025.113992_bb0175","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2147\/IJN.S190502","article-title":"Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization","volume":"14","author":"Khames","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113992_bb0180","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3390\/pharmaceutics14091961","article-title":"Optimization of lipid nanoparticles by response surface methodology to improve the ocular delivery of Diosmin: characterization and in vitro anti-inflammatory assessment","volume":"14","author":"Zingale","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12060584","article-title":"Topical administration of sln-based gene therapy for the treatment of corneal inflammation by de novo il-10 production","volume":"12","author":"Vicente-Pascual","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1371-6","article-title":"Development, optimization, and in vitro\/in vivo characterization of enhanced lipid nanoparticles for ocular delivery of ofloxacin: the influence of pegylation and chitosan coating","volume":"20","author":"Eid","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2025.113992_bb0195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/nnm-2018-0278","article-title":"Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics","volume":"14","author":"Singh","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113992_bb0200","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/10717544.2020.1756984","article-title":"Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment","volume":"27","author":"Liu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.113992_bb0205","article-title":"Efficient delivery of hydrophilic small molecules to retinal cell lines using gel core-containing solid lipid nanoparticles","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/1061186X.2020.1871483","article-title":"Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment","volume":"29","author":"Kakkar","year":"2021","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2025.113992_bb0215","author":"Brita Schulze"},{"key":"10.1016\/j.jconrel.2025.113992_bb0220","author":"Bilodeau"},{"key":"10.1016\/j.jconrel.2025.113992_bb0225","author":"Giuseppe"},{"key":"10.1016\/j.jconrel.2025.113992_bb0230","author":"Russo"},{"key":"10.1016\/j.jconrel.2025.113992_bb0235","author":"Garc\u00eda"},{"key":"10.1016\/j.jconrel.2025.113992_bb0240","author":"Iraj Mehrnia"},{"key":"10.1016\/j.jconrel.2025.113992_bb0245","author":"Qunwei"},{"key":"10.1016\/j.jconrel.2025.113992_bb0250","author":"Gang Wei"},{"key":"10.1016\/j.jconrel.2025.113992_bb0255","author":"Simon Kaja"},{"key":"10.1016\/j.jconrel.2025.113992_bb0260","author":"Indu"},{"key":"10.1016\/j.jconrel.2025.113992_bb0265","author":"Gautam Behl"},{"key":"10.1016\/j.jconrel.2025.113992_bb0270","author":"Blanco"},{"key":"10.1016\/j.jconrel.2025.113992_bb0275","author":"Zou Liang"},{"key":"10.1016\/j.jconrel.2025.113992_bb0280","author":"Gasc\u00f3n"},{"key":"10.1016\/j.jconrel.2025.113992_bb0285","author":"Milane"},{"key":"10.1016\/j.jconrel.2025.113992_bb0290","author":"Sloat"},{"key":"10.1016\/j.jconrel.2025.113992_bb0295","author":"Gu Lingling"},{"key":"10.1016\/j.jconrel.2025.113992_bb0300","series-title":"Applications of Flavonoids, With an Emphasis on Hesperidin, as Anticancer Prodrugs: Phytotherapy as an Alternative to Chemotherapy, in: Stud. Nat. Prod. Chem","first-page":"161","author":"Stanisic","year":"2018"},{"key":"10.1016\/j.jconrel.2025.113992_bb0305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113992_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112229","article-title":"Comparison between HET-CAM protocols and a product use clinical study for eye irritation evaluation of personal care products including cosmetics according to their surfactant composition","volume":"153","author":"Rivero","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0315","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.addr.2006.07.025","article-title":"Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling","volume":"58","author":"Ranta","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113992_bb0320","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","article-title":"Transport barriers in transscleral drug delivery for retinal diseases","volume":"39","author":"Kim","year":"2007","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2025.113992_bb0325","doi-asserted-by":"crossref","first-page":"2165736","DOI":"10.1080\/10717544.2023.2165736","article-title":"Application of iontophoresis in ophthalmic practice: an innovative strategy to deliver drugs into the eye","volume":"30","author":"Wei","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.113992_bb0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2024.05.013","article-title":"Hollow microneedles for ocular drug delivery","volume":"371","author":"Gade","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113992_bb0335","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/biom12020223","article-title":"A stepwise framework for the systematic development of lipid nanoparticles","volume":"12","author":"Basso","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2025.113992_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071916","article-title":"Artificial intelligence in pharmaceutical technology and drug delivery design","volume":"15","author":"Vora","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0345","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1568026620666201126162945","article-title":"Computational and experimental approaches to investigate lipid nanoparticles as drug and gene delivery systems","volume":"21","author":"Chan","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.113992_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8020010","article-title":"Small angle X-ray and neutron scattering: powerful tools for studying the structure of drug-loaded liposomes","volume":"8","author":"Di Cola","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0355","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.3390\/molecules25235624","article-title":"Structural characterization of biomaterials by means of small angle x-rays and neutron scattering (Saxs and sans), and light scattering experiments","volume":"25","author":"Lombardo","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.113992_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007870","article-title":"RESEARCH ARTICLE combining molecular dynamics simulations with small-angle X-ray and neutron scattering data to study multi-domain proteins in solution","volume":"16","author":"Larsen","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0365","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jcis.2024.02.076","article-title":"Small-angle X-ray scattering unveils the internal structure of lipid nanoparticles","volume":"662","author":"Spinozzi","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2025.113992_bb0370","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/pharmaceutics14122704","article-title":"Tailoring lipid-based drug delivery nanosystems by synchrotron small angle X-ray scattering","volume":"14","author":"Sartori","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113992_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/640436","article-title":"Small angle X-Ray scattering technique for the particle size distribution of nonporous nanoparticles","volume":"2013","author":"Agbabiaka","year":"2013","journal-title":"J. Nanopart."},{"key":"10.1016\/j.jconrel.2025.113992_bb0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejpb.2016.07.019","article-title":"Towards better modelling of drug-loading in solid lipid nanoparticles: molecular dynamics, docking experiments and Gaussian processes machine learning","volume":"108","author":"Hathout","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113992_bb0385","article-title":"Lipid based nanocarriers: production techniques, concepts, and commercialization aspect","volume":"74","author":"Kumar","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113992_bb0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.113992_bb0395","first-page":"143","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics, nanomedicine nanotechnology","volume":"12","author":"Beloqui","year":"2016","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2025.113992_bb0400","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the scale-up methods for the preparation of solid lipid nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:18:21Z","timestamp":1778944701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925006133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":80,"alternative-id":["S0168365925006133"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113992","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative solid lipid nanoparticle formulations for ocular therapeutics and related patents: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113992"}}